Tarik Hadid
Impact in
- Internal Medicine top 10%
- Venous Thromboembolism Diagnosis and Management
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
- Co-authors
- Ayad Al-Katib (4 shared papers)Uqba Khan (9 shared papers)Farman Ali (1 shared paper)Jane Chiu (1 shared paper)Jason Mouabbi (11 shared papers)Haidy Elazzamy (1 shared paper)Susan Szpunar (4 shared papers)Jillian Frieder (1 shared paper)
- Journals
- Journal of Clinical Oncology (9 papers)Blood (5 papers)CHEST Journal (3 papers)Cancer Medicine (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)
- Partner nations
- United StatesIndiaUnited Kingdom
In The Last Decade
Tarik Hadid
40 papers receiving 354 citations
Peers
Comparison fields: 5 of 59
- Internal Medicine 22
- Infectious Diseases 88
- Oncology 103
- Hematology 42
- Neurology 46
Countries citing papers authored by Tarik Hadid
This map shows the geographic impact of Tarik Hadid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tarik Hadid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tarik Hadid more than expected).
Fields of papers citing papers by Tarik Hadid
This network shows the impact of papers produced by Tarik Hadid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tarik Hadid. The network helps show where Tarik Hadid may publish in the future.
Co-authors
The 25 scholars most cited alongside Tarik Hadid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 134 | |
| 2 | 2017 | 53 | |
| 3 | 2017 | 39 | |
| 4 | 2017 | 18 | |
| 5 | 2016 | 12 | |
| 6 | 2020 | 10 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 8 | |
| 9 | 2017 | 7 | |
| 10 | 2024 | 6 | |
| 11 | 2025 | 5 | |
| 12 | 2016 | 4 | |
| 13 | 2021 | 4 | |
| 14 | 2020 | 4 | |
| 15 | 2017 | 4 | |
| 16 | 2023 | 4 | |
| 17 | 2016 | 3 | |
| 18 | 2021 | 3 | |
| 19 | 2016 | 3 | |
| 20 | 2017 | 3 |
About Tarik Hadid
Tarik Hadid is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Hematology and Genetics, having authored 45 papers that have together received 359 indexed citations. Recurring topics across this work include Cancer Diagnosis and Treatment (3 papers), Vascular Malformations and Hemangiomas (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Vascular Procedures and Complications (2 papers), Cannabis and Cannabinoid Research (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Internal Medicine (22 citations), Infectious Diseases (88 citations), Oncology (103 citations), Hematology (42 citations) and Neurology (46 citations). Tarik Hadid has collaborated with scholars based in United States, India and United Kingdom. Frequent co-authors include Ayad Al-Katib, Uqba Khan, Farman Ali, Jane Chiu, Jason Mouabbi, Haidy Elazzamy, Susan Szpunar, Jillian Frieder, Ahmed Abdalla and Ameer Hamza. Their work appears in journals such as Journal of Clinical Oncology, Blood, CHEST Journal, Cancer Medicine and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.